SCHEMBL1960427

SCHEMBL1960427

Fc1ccc(-n2ccc(-c3ccc(Cl)nn3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
NOTUM Q6P988 1/20 0.38
UBE2N P61088 4/20 0.37
MAPT P10636 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
FLT3 P36888 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 2/20 0.33
PDE5A O76074 1/20 0.33
PDE4B Q07343 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
RXRA P19793 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
FAAH O00519 5/20 0.32
MGLL Q99685 3/20 0.32
KCNH2 Q12809 2/20 0.32
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1961169 0.77 KMT2A (0.39) KMT2ANOTUMUBE2NMAPTL3MBTL1
SCHEMBL1964445 0.74 CA1 (0.38) KMT2AMAPTKDM4EFLT3ALDH1A1
SCHEMBL29664672 0.70 RAB9A (0.52) KMT2AMAPTL3MBTL1KDM4EALDH1A1
SCHEMBL1686039 0.70 RAB9A (0.52) KMT2AMAPTL3MBTL1KDM4EALDH1A1
SCHEMBL19120907 0.70 FLT3 (0.61) KMT2ANOTUML3MBTL1KDM4EFLT3
SCHEMBL31334034 0.69 KMT2A (0.38) KMT2ANOTUMUBE2NMAPTL3MBTL1
SCHEMBL1456362 0.69 ALDH1A1 (0.46) KMT2AMAPTL3MBTL1KDM4EALDH1A1
SCHEMBL24573099 0.68 SCN4A (0.44) KMT2ANOTUMMAPTL3MBTL1KDM4E
SCHEMBL1959479 0.68 GRM5 (0.46) KMT2AKDM4EKCNH2
SCHEMBL27260683 0.67 POLB (0.48) KMT2AMAPTL3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2299824-B1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME (US) 2013-06-19 EP disclosed
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-06-16 US disclosed
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-06-16 US disclosed
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144056-A1 PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HRH2 KMT2A 1541/4885NOTUM 562/4885UBE2N 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.